TOP NEWS

Pathology Inc.'s Take: $24.65M

The October funding of Torrance-based Pathology, Inc. was worth $24.65M, according to new numbers revealed over the weekend in the PricewaterhouseCoopers/NVCA MoneyTree report. According to the report, the firm raised $24.65M in Q4. The firm had announced the Series A investment from ABS Capital Partners in October. Pathology, Inc. provides pathology and molecular diagnostics services. The firm's funding was one of the largest reported in Southern California in Q4. More information »


RELATED COMPANIES


RELATED STORIES

MARKETPLACE